Has_Pharmaceutical_Release_Characteristics
A21
An association that specifies the timing by which an active ingredient is made available in the body after administration of the pharmaceutical product, in comparison with a conventional, direct release of the active ingredient. The target value should belong to the EDQM-HC Release Characteristics Terminology.
Conceptual Entity
Has_Pharmaceutical_Release_Characteristics
Has_Pharmaceutical_Release_Characteristics
Release Characteristics